Assessing the Reliability and Validity of 4-meter and 10-meter Walking Test

July 26, 2022 updated by: Rosa Cabanas Valdés, Universitat Internacional de Catalunya

Assessing the Reliability and Validity of 4-meter and 10-meter Walking Test for Measurements of Gait Speed and Their Correlation With 5-repetition Sit-to-stand Test in Chronic Stroke Survivors

The 4-meter walk test and 10-meter walk test is currently applied to assess gait speed.These tools are frequently used in clinical trials and were also shown to be reliable measurement methods. There are ocassions where it is not possible to have a long corridor to measure gait speed. It is necessary to have a tool to evaluate gait speed in a small space as 4-meter walk test.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Walking speed is an important aspect of gait and is commonly used as an objective measure of functional mobility in both clinical and research settings. The majority who have suffered a stroke tend to have gait disturbances. Regaining locomotor ability is one of the primary goals in stroke rehabilitation, and it is most commonly measured using changes in self-selected walking speed. Although many of them can walk independently, they do not do so with enough speed and endurance to allow them to perform their activities of daily living prior to stroke. Not only is self-selected walking speed simple, cost effective, reliable, valid, sensitive, and specific, but it is also highly related to the severity of impairment and predicts functional walking status. It is recommended as a "vital sign" of health. Improvements in walking speed of 0.1 m/s or more have been shown to be a predictor of good health. However, decreased walking speed has been related to worse health outcomes and frailty in older people.

The 4-meter walk test (4 MWT) and 10-meter walk test (10 MWT) is currently applied using various timing protocols and distance covered that may affect data interpretation with a standard value, and comparisons among the studies. There are two protocols to measure walking speed, static and flying start. A static start (i.e., record the time used to cover a total walkway or from the start to stop walking) or a flying start (i.e., measured the time while walking in the middle of the walkway).

The aim of this study is to investigate the test-retest reliability of the 4 MWT and 10 MWT and their correlation with 5-repetition sit-to-stand in chronic stroke survivors.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Barcelona, Spain, 08195
        • Universitat Internacional de Catalunya

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Stroke survivors in chronic phase > 6 months

Description

Inclusion Criteria:

  • All study participants are clinically diagnosed with stroke
  • Adult participants, defined as >18 years of age
  • Have preserved cognitive ability: Achieve a score equal to or greater than 25 points on the Montreal Cognitive Assessment test.
  • Have the ability to walk on a flat surface of at least 20 meters, with or without aid.

Exclusion Criteria:

  • A history of lower extremities injury or surgery
  • A history of botulinum injection within 3 months
  • A history of inflammatory arthritis
  • A history of inflammatory myopathy or peripheral nervous disease
  • A history of other neurological disease as a Parkinson, spinal cord etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Stroke survivors
Chronic stroke, generally speaking chronic stroke refers to the period of recovery that takes place at least six months after the initial stroke event
Other: Assessment
The participants walk 4-meter and 10-meter and 5-repetition sit-to-stand twice.
Other Names:
  • Evaluation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reliability of 4-meter walking test
Time Frame: Baseline
Reliability is the overall consistency of a measure.
Baseline
Reliability of 4-meter walking test
Time Frame: 1 hour later from baseline
Reliability is the overall consistency of a measure.
1 hour later from baseline
Validity of 4-meter walking test
Time Frame: Baseline
Validity is the extent to which a concept, conclusion or measurement is well-founded and likely corresponds accurately to the real world
Baseline
Validity of 4-meter walking test
Time Frame: 1 hour later from baseline
Validity is the extent to which a concept, conclusion or measurement is well-founded and likely corresponds accurately to the real world
1 hour later from baseline
Reliability of 10-meter walking test
Time Frame: Baseline
Reliability is the overall consistency of a measure.
Baseline
Reliability of 10-meter walking test
Time Frame: 1 hour later from baseline
Reliability is the overall consistency of a measure.
1 hour later from baseline
Validity of 10-meter walking test
Time Frame: Baseline
Validity is the extent to which a concept, conclusion or measurement is well-founded and likely corresponds accurately to the real world
Baseline
Validity of 10-meter walking test
Time Frame: 1 hour later from baseline
Validity is the extent to which a concept, conclusion or measurement is well-founded and likely corresponds accurately to the real world
1 hour later from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of 5-repetition sit-to-stand with 4-meter walking test
Time Frame: Baseline
A rank correlation coefficient measures the degree of similarity between two rankings, and can be used to assess the significance of the relation between them.
Baseline
Correlation of 5-repetition sit-to-stand with 10-meter walking test
Time Frame: Baseline
A rank correlation coefficient measures the degree of similarity between two rankings, and can be used to assess the significance of the relation between them.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universitat Internacional de Catalunya

Collaborators

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Investigators

  • Study Director: Laura García-Rueda, MsC, Universitat Internacional de Catalunya

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

December 29, 2021

Study Completion (Actual)

December 30, 2021

Study Registration Dates

First Submitted

May 23, 2021

First Submitted That Met QC Criteria

June 3, 2021

First Posted (Actual)

June 9, 2021

Study Record Updates

Last Update Posted (Actual)

July 27, 2022

Last Update Submitted That Met QC Criteria

July 26, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4-meter walking test

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Assessment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe